Cite
B-Raf inhibitor vemurafenib counteracts sulfur mustard-induced epidermal impairment through MAPK/ERK signaling.
MLA
Xiao, Zhiyong, et al. “B-Raf Inhibitor Vemurafenib Counteracts Sulfur Mustard-Induced Epidermal Impairment through MAPK/ERK Signaling.” Drug & Chemical Toxicology, vol. 46, no. 2, Mar. 2023, pp. 226–35. EBSCOhost, https://doi.org/10.1080/01480545.2021.2021927.
APA
Xiao, Z., Liu, F., Cheng, J., Wang, Y., Zhou, W., & Zhang, Y. (2023). B-Raf inhibitor vemurafenib counteracts sulfur mustard-induced epidermal impairment through MAPK/ERK signaling. Drug & Chemical Toxicology, 46(2), 226–235. https://doi.org/10.1080/01480545.2021.2021927
Chicago
Xiao, Zhiyong, Feng Liu, Junping Cheng, Ying Wang, Wenxia Zhou, and Yongxiang Zhang. 2023. “B-Raf Inhibitor Vemurafenib Counteracts Sulfur Mustard-Induced Epidermal Impairment through MAPK/ERK Signaling.” Drug & Chemical Toxicology 46 (2): 226–35. doi:10.1080/01480545.2021.2021927.